首页> 外国专利> A PHARMACEUTICAL COMPOSITION FOR TREATING NEUROPATHIC PAIN COMPRISING GABAERGIC NEURONS, WHICH IS ADIPOSE TISSUE-DERIVED STEM CELL(ATSCS) DIFFERENTIATED BY CBM-1078 AS ACTIVE INGREDIENTS

A PHARMACEUTICAL COMPOSITION FOR TREATING NEUROPATHIC PAIN COMPRISING GABAERGIC NEURONS, WHICH IS ADIPOSE TISSUE-DERIVED STEM CELL(ATSCS) DIFFERENTIATED BY CBM-1078 AS ACTIVE INGREDIENTS

机译:一种药物治疗组合物,用于治疗由加伯尔格神经元组成的神经痛,其是由CBM-1078分化为活性成分的脂肪组织干细胞(ATSCS)

摘要

PURPOSE: A pharmaceutical composition containing GABAergic neurons which is differentiated by treating adipose-derived stem cells with CBM-1078 for preventing and treating neuropathic pain is provided to protect neurons, and to regenerates nerves. CONSTITUTION: A method for differentiating adult stem cells to GABAergic neurons comprises a step of culturing the adult stem cells in a differentiation medium containing a low molecular compound. The low molecular compound induces neurons, and is CBM-1078. The adult stem cells are derived from adipose. The concentration of the low molecular compound is 0.2-5 nM.
机译:目的:提供一种含有GABA能神经元的药物组合物,该药物组合物通过用CBM-1078治疗脂肪干细胞来预防和治疗神经性疼痛而分化,以保护神经元并再生神经。组成:一种将成年干细胞分化为GABA能神经元的方法,包括在含有低分子化合物的分化培养基中培养成年干细胞的步骤。该低分子化合物诱导神经元,为CBM-1078。成年干细胞来源于脂肪。低分子化合物的浓度为0.2-5nM。

著录项

  • 公开/公告号KR20130050663A

    专利类型

  • 公开/公告日2013-05-16

    原文格式PDF

  • 申请/专利权人 SNU R&DB FOUNDATION;

    申请/专利号KR20110115861

  • 发明设计人 KANG SOO KYUNG;

    申请日2011-11-08

  • 分类号A61K31/381;A61K31/38;A61K35/12;A61P25;

  • 国家 KR

  • 入库时间 2022-08-21 16:27:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号